A new molecule to check: ADA‑308 in vivo proved to be a potent AR inhibitor against enzalutamide‑resistant prostate cancer

[Maxone73]

Ok, we must wait at least for a phase 1 study, but since the molecule has already a name it makes me think it has been patented already, so clinical studies should not be far away.

spandidos-publications.com/...

[Justfor_]

Can you check a publication on "Nature Machine Intelligence" by Pushpak Pati and al, regarding an AI model, named "Virtual multiplexer", developed at the University of Lausanne and give us your thoughts about it?

[Maxone73 in reply to Justfor_]

Great catch!!! My semiprofessional opinion is in technical terms is WTF!!!

A tool like this interfaced with AlphaFold and AlphaProteo could be a blessing for all kinds of cancer research! It's incredible how the part of AI (of machine learning to be precise) that takes care of creating synthetic data to use it to train complex models has evolved. When I was studying these things, synthetic data were what you used when you really had a training population that was too small to train a neural network. Last resort was trying to produce realistic synthetic data. Now they became a standard, also because real data are starting to become scarce!